Larvol Delta - Safety-and-Tolerability-of-KH658-Gene-Therapy-in-Subjects-With-Neovascular-Agerelated-Macular-Degeneration-nAMD

KH658 - Chengdu Kanghong Pharma

http://clinicaltrials.gov/ct2/show/NCT06458595

Nov 29, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next